Rep. April McClain Delaney Sells Shares of Labcorp Holdings Inc. (NYSE:LH)

Key Points

• Rep. April McClain Delaney sold between $1,001 and $15,000 of Labcorp shares on August 7, according to a September 9 disclosure. She also reported selling stakes in several other companies, including Wabtec, Viking, Trimble and TransDigm.
• Labcorp recently beat quarterly expectations, reporting $4.99 earnings per share versus the $4.78 consensus and $3.73 billion in revenue, up 5.8% year over year. The company guided to fiscal 2026 EPS of $18.10–$18.55.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $330, while Labcorp pays a quarterly dividend of $0.72 per share. The stock was trading near $307.77, down 4.2%.

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of Labcorp Holdings Inc. NYSE: LH. In a filing disclosed on September 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in Labcorp stock on August 7th.

Representative April McClain Delaney also recently made the following trade(s):

• Sold $100,001 - $250,000 in shares of Wabtec NYSE: WAB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Viking NYSE: VIK on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Trimble NASDAQ: TRMB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Transdigm Group NYSE: TDG on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Tractor Supply NASDAQ: TSCO on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Middleby NASDAQ: MIDD on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Teledyne Technologies NYSE: TDY on 8/25/2026.
• Sold $100,001 - $250,000 in shares of STERIS NYSE: STE on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Somnigroup International NYSE: SGI on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Signet Jewelers NYSE: SIG on 8/25/2026.

Labcorp Trading Down 4.2%

NYSE:LH opened at $307.77 on Friday. The company has a market cap of $24.96 billion, a PE ratio of 25.46, a P/E/G ratio of 1.82 and a beta of 0.88. The business's 50 day moving average is $309.90 and its two-hundred day moving average is $281.74. The company has a quick ratio of 1.53, a current ratio of 1.80 and a debt-to-equity ratio of 0.69. Labcorp Holdings Inc. has a 52 week low of $244.52 and a 52 week high of $341.80.

Labcorp (NYSE:LH - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical research company reported $4.99 earnings per share for the quarter, beating analysts' consensus estimates of $4.78 by $0.21. Labcorp had a return on equity of 16.74% and a net margin of 6.99%.The business had revenue of $3.73 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same period in the previous year, the business earned $4.35 EPS. The business's quarterly revenue was up 5.8% on a year-over-year basis. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. On average, analysts predict that Labcorp Holdings Inc. will post 18.32 EPS for the current year.

Labcorp Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, August 28th. Labcorp's dividend payout ratio (DPR) is currently 23.82%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on LH shares. Mizuho set a $355.00 price target on shares of Labcorp in a research report on Monday, August 10th. Piper Sandler increased their price target on Labcorp from $300.00 to $309.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 4th. Bank of America increased their price objective on shares of Labcorp from $300.00 to $320.00 and gave the company a "buy" rating in a report on Monday, July 13th. Truist Financial lifted their target price on Labcorp from $320.00 to $350.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $306.00 price target on shares of Labcorp in a report on Friday, July 31st. Nine equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $330.00.

Institutional Investors Weigh In On Labcorp

Institutional investors have recently bought and sold shares of the business. Brighton Jones LLC purchased a new position in shares of Labcorp during the 4th quarter valued at $991,000. Integrated Wealth Concepts LLC raised its holdings in shares of Labcorp by 7.9% during the first quarter. Integrated Wealth Concepts LLC now owns 2,427 shares of the medical research company's stock worth $565,000 after acquiring an additional 177 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Labcorp by 52.2% during the first quarter. Goldman Sachs Group Inc. now owns 353,843 shares of the medical research company's stock valued at $82,353,000 after purchasing an additional 121,304 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in Labcorp during the second quarter valued at $5,873,000. Finally, First Trust Advisors LP grew its stake in Labcorp by 83.2% in the second quarter. First Trust Advisors LP now owns 86,046 shares of the medical research company's stock valued at $22,588,000 after purchasing an additional 39,087 shares in the last quarter. 95.94% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Kerrii Anderson sold 3,000 shares of the firm's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $318.02, for a total transaction of $954,060.00. Following the completion of the sale, the director directly owned 6,563 shares of the company's stock, valued at $2,087,165.26. This trade represents a 31.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Adam Schechter sold 4,669 shares of Labcorp stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $320.37, for a total value of $1,495,807.53. Following the sale, the chief executive officer owned 102,565 shares of the company's stock, valued at approximately $32,858,749.05. This represents a 4.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 8,919 shares of company stock worth $2,826,593. Insiders own 0.84% of the company's stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

Labcorp Company Profile

Labcorp NYSE: LH, formerly Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing and related services to physicians, hospitals, health systems, employers, government agencies and consumers.

Its diagnostics business offers routine and specialty laboratory testing, including molecular, genetic, oncology, women's health, infectious disease and pathology services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.